medlive.cn
medlive.cn (医脉通) is a Chinese medical information and clinical decision support platform serving practicing physicians across 28+ specialties, monetizing via pharma marketing channels, subscriptions, CME courses, and clinical trial technology.
- Company typePrivate
- Founded2005
- HeadquartersBeijing, China
- Headcount251–500
- GTM typeB2B and B2C
- OfferingSoftware
What medlive.cn does
medlive.cn (医脉通), operated by Beijing Medlive Interchange Technology Co., Ltd. and publicly listed on HKEX (ticker 2192), is a Chinese medical information and clinical decision support platform serving practicing physicians, specialists, and pharmaceutical companies across 28+ medical departments including cardiology, oncology, neurology, hepatology, and hematology. The platform aggregates clinical guidelines, disease knowledge bases, drug references, medical literature search, conference coverage, and case-based learning content, distributed through a main website, native mobile apps, WeChat mini-programs, and dedicated department-specific sub-sites. Its core technology stack includes MedSeeker (an NLP-based clinical Q&A tool), a GPT-based medical assistant, and MedPaper for AI-assisted manuscript writing, all grounded in the platform's proprietary clinical content corpus.
The business operates a dual-sided model. On the supply side, Medlive monetizes a large base of Chinese physicians through pharma marketing services — branded messaging channels (e信使/eMessenger), educational broadcasts (e脉播/eBroadcast), sponsored content, and enterprise columns for global pharma (Eli Lilly, GSK, Bayer, Sanofi, Novo Nordisk, Merck) and domestic leaders (Hengrui, Tasly). On the demand side, individual physicians access most content for free and pay for VIP subscriptions, premium CME courses (¥199-¥499), and tools such as clinical calculators and literature management software. Additional revenue streams include clinical trial technology (EDC, DCT, Digital Intelligence Platform), research services (omics analysis, translation, journal selection), career services, and recruitment. The company was founded in 2005 in Beijing and holds regulatory certifications including Internet Drug and Medical Device Information Service filing and Publication Business License.
medlive.cn firmographics
Firmographics- Name
- medlive.cn
- Legal name
- 北京医脉互通科技有限公司
- Website
- https://medlive.cn
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- medlive.cn (医脉通) is a Chinese medical information and clinical decision support platform serving practicing physicians across 28+ specialties, monetizing via pharma marketing channels, subscriptions, CME courses, and clinical trial technology.
- Ownership category
- akta.pro rank
medlive.cn industry classification
Industry- Product category
- Healthcare Professional Platform
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)
- akta.pro secondary industries
- Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
Keywords
Where medlive.cn is headquartered
LocationHeadquarters
- HQ city
- Beijing
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
medlive.cn business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Pharmaceutical Company Marketing Services: Medlive provides pharmaceutical companies with marketing channels to reach medical professionals through brand messaging platforms (品牌信使), enterprise columns (企业专栏), and targeted medical communications. Companies like GlaxoSmithKline, Eli Lilly, and Hengrui Medicine maintain presence on the platform.
- VIP Subscription Services: The platform offers VIP subscriptions for advanced features including premium clinical guidelines, exclusive educational content, and discount coupons for medical resources. Users earn '麦粒' (Maili points) through daily check-ins that can be redeemed for premium services.
- Medical Education and Conference Services: The platform organizes and broadcasts medical conferences and provides premium educational courses, some available for paid enrollment. Courses like '心力衰竭规范化诊疗系列讲座' are priced at ¥399 with discounts to ¥199.
- Medical Software and Tools: The platform distributes various medical software tools including literature management (医学文献王), medical dictionaries, clinical calculators, and specialized medical applications through its software center.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Basic Free Tier - Access to core platform features including medical news, guidelines, cases, and community features |
| Subscription | One time/ perpetual license | Premium Courses - Paid medical education content including video lectures and specialized training programs |
| Subscription | Annual | VIP Subscription - Premium membership with exclusive features and discounts |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
medlive.cn product offering
Product offeringCore offering
Medlive.cn operates a medical professional platform serving Chinese physicians with clinical decision support tools including the MedSeeker AI system, comprehensive clinical guidelines database, drug reference tools, and disease knowledge bases spanning 28+ medical specialties. The platform also provides pharmaceutical companies with branded marketing channels to reach physicians, and offers continuing medical education through webinars, conferences, and case-based learning content.
Product overview
Medlive.cn (医脉通) is a comprehensive medical professional platform offering an integrated ecosystem of clinical decision support tools and services. The platform architecture consists of a core clinical knowledge base (临床知识库) supplemented by specialized modules including MedSeeker AI for intelligent clinical decision support, the Clinical Guidelines database (临床指南), Drug Reference (用药参考), and Disease Knowledge Base (疾病知识库). Additional modules span research services (e研通, MedPaper), education (e学院, 知识银行, e脉播), clinical trial technology (EDC, DCT, 数智化平台), communication (e信使), literature retrieval (医学文献王), and specialty content across 30+ medical departments including Cardiology, Oncology, Neurology, and Hepatology. The platform also includes consumer-facing mobile applications and AI-powered tools like GPT for medical inquiries.
Differentiator
Problem solved
Functional benefit
Brands
- MedSeeker: AI-powered clinical decision support tool
- e信使 (eMessenger)
- e脉播 (eBroadcast)
- e研通 (eYanTong)
- 知识银行 (Knowledge Bank)
- 用药参考 (Drug Reference)
- 临床指南 (Clinical Guidelines)
Products and services
- MedSeeker
- Clinical Guidelines (临床指南)
- Drug Reference (用药参考)
- Disease Knowledge Base (疾病知识库)
- eMessenger (e信使)
- eBroadcast (e脉播)
- eResearch (e研通)
- Knowledge Bank (知识银行)
- Medical Literature King (医学文献王)
- EDC (Electronic Data Capture)
- DCT (Decentralized Clinical Trials)
- Medlive Mobile App (医脉通APP)
- GPT Medical AI Assistant
- MedPaper
- eAcademy (e学院)
- Medical Conferences (医学会议)
- Medical Dictionary (医学大词典)
- Clinical Cases (临床病例)
- Medical Visualization (医脉可视)
- Medical Translation (医心医译)
- Medlive Career (医脉人才)
- Calculation Formulas (计算公式)
- Journal Selection & Submission (选刊投稿)
Quantifiable outcome
- MedSeeker AI provides evidence-based clinical recommendations with citations from authoritative medical sources
Companies that use medlive.cn
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles2 records
medlive.cn technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
medlive.cn partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, major and minor.
- Memorial Sloan Kettering Cancer CentercoreMedlive appointed Dr. Ghassan Abou-Alfa, a specialist from Memorial Sloan Kettering Cancer Center, to its Advisory Board to strengthen educational programming in hepatobiliary cancers, bringing clinical and research expertise from this leading US cancer center.
- Sarah Cannon Research InstitutecoreMedlive appointed Dr. Hans Lee from Sarah Cannon Research Institute to its Advisory Board to enhance educational content in multiple myeloma, leveraging expertise from this prominent US research institute focused on cancer therapeutics.
- UCLA (University of California, Los Angeles)coreMedlive appointed Dr. Aaron Lisberg from UCLA to its Advisory Board to strengthen thoracic oncology educational programming, bringing academic medical center expertise to the platform.
- GlaxoSmithKline China (葛兰素史克(中国)投资有限公司)majorGlaxoSmithKline maintains a branded messaging channel (哮喘云学院) on Medlive's e信使 platform with 69,262 followers, providing asthma education content to Chinese physicians.
- Eli Lilly (礼来)majorEli Lilly operates 达摩院 messaging channel on Medlive with 204,278 followers and 107,375 total reads, providing medical information related to their oncology and diabetes products.
- Jiangsu Hengrui Medicine (江苏恒瑞医药股份有限公司)majorHengrui Medicine maintains 瑞达学苑 brand messaging channel on Medlive for physician education and medical communications.
- Bayer Healthcare China (拜耳医药保健有限公司)majorBayer operates multiple brand messaging channels on Medlive including拜阿司匹灵, 拜瑞妥, and 拜小妥 with combined reach of over 760,000 interactions for cardiovascular and anticoagulation products.
- Novo Nordisk China (诺和诺德(中国)制药有限公司)majorNovo Nordisk maintains medical communications channels on Medlive for diabetes and cardiovascular products, including 灵丹 channel and 医线心泰 platform.
- Sanofi China (赛诺菲)majorSanofi operates multiple channels on Medlive including 基层医疗 and IH (International Health) divisions, reaching hundreds of thousands of physicians with cardiovascular and specialty medicine content.
- Tasly Pharmaceutical Group (天士力医药集团股份有限公司)minorTasly maintains 芪小参 brand messaging presence on Medlive for traditional Chinese medicine and cardiovascular product communications.
- Merck China (默克(中国))majorMerck operates 康忻 (cardiovascular) and 怡可安 (diabetes) brand messaging channels on Medlive reaching over 60,000 physicians.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
medlive.cn competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
medlive.cn compliance and trust
Trust signalCompliance5 records
medlive.cn financial estimates
Financial estimateRevenue estimate
Valuation estimate
medlive.cn leadership team
Management profileNumber of profiles
Profiles2 records
medlive.cn funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
medlive.cn M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about medlive.cn
What does medlive.cn do?
Medlive.cn operates a medical professional platform serving Chinese physicians with clinical decision support tools including the MedSeeker AI system, comprehensive clinical guidelines database, drug reference tools, and disease knowledge bases spanning 28+ medical specialties. The platform also provides pharmaceutical companies with branded marketing channels to reach physicians, and offers continuing medical education through webinars, conferences, and case-based learning content.
Is medlive.cn a public or private company?
medlive.cn is a private company. It is classified as public and is currently operating.
When was medlive.cn founded?
medlive.cn was founded in 2005. It employs 251 to 500 people.
Where is medlive.cn based?
medlive.cn is headquartered in Beijing, China, in the Asia region.
How does medlive.cn make money?
Four revenue lines are on record. Pharmaceutical Company Marketing Services are the primary driver. The others are VIP Subscription Services, medical Education and Conference Services and medical Software and Tools.
Does medlive.cn have an API?
No public API is recorded for medlive.cn.
What industry is medlive.cn in?
medlive.cn's product category is Healthcare Professional Platform. Its primary akta.pro industry code is EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health), with a secondary code of EDAAALAC, Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy). Its NAICS code is 5417 and its SIC code is 8000.